Open AccessRenin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure
Author(s) -
Emmanuel Sorbets,
Julien Labreuche,
Tabassome Simon,
Laurent Delorme,
Nicolás Danchin,
Pierre Amarenco,
Shinya Goto,
Christophe Meune,
Kim A. Eagle,
Deepak L. Bhatt,
Philippe Gabriel Steg
Publication year - 2014
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehu078
Subject(s) - medicine , hazard ratio , heart failure , coronary artery disease , cardiology , propensity score matching , stroke (engine) , myocardial infarction , confidence interval , angiotensin receptor , renin–angiotensin system , blood pressure , mechanical engineering , engineering
The aim of this study was to determine whether angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-II receptor blocker (ARB) use is associated with lower rates of cardiovascular events in patients with stable coronary artery disease (CAD) but without heart failure (HF) receiving contemporary medical management.